These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
438 related articles for article (PubMed ID: 15557655)
1. Mannose-resistant Proteus-like fimbriae are produced by most Proteus mirabilis strains infecting the urinary tract, dictate the in vivo localization of bacteria, and contribute to biofilm formation. Jansen AM; Lockatell V; Johnson DE; Mobley HL Infect Immun; 2004 Dec; 72(12):7294-305. PubMed ID: 15557655 [TBL] [Abstract][Full Text] [Related]
2. Fimbriae of uropathogenic Proteus mirabilis. Rocha SP; Pelayo JS; Elias WP FEMS Immunol Med Microbiol; 2007 Oct; 51(1):1-7. PubMed ID: 17640292 [TBL] [Abstract][Full Text] [Related]
3. In vivo phase variation of MR/P fimbrial gene expression in Proteus mirabilis infecting the urinary tract. Zhao H; Li X; Johnson DE; Blomfield I; Mobley HL Mol Microbiol; 1997 Mar; 23(5):1009-19. PubMed ID: 9076737 [TBL] [Abstract][Full Text] [Related]
4. Mannose-resistant Proteus-like and P. mirabilis fimbriae have specific and additive roles in P. mirabilis urinary tract infections. Zunino P; Sosa V; Schlapp G; Allen AG; Preston A; Maskell DJ FEMS Immunol Med Microbiol; 2007 Oct; 51(1):125-33. PubMed ID: 17854474 [TBL] [Abstract][Full Text] [Related]
5. Requirement of MrpH for mannose-resistant Proteus-like fimbria-mediated hemagglutination by Proteus mirabilis. Li X; Johnson DE; Mobley HL Infect Immun; 1999 Jun; 67(6):2822-33. PubMed ID: 10338487 [TBL] [Abstract][Full Text] [Related]
7. Identification of MrpI as the sole recombinase that regulates the phase variation of MR/P fimbria, a bladder colonization factor of uropathogenic Proteus mirabilis. Li X; Lockatell CV; Johnson DE; Mobley HL Mol Microbiol; 2002 Aug; 45(3):865-74. PubMed ID: 12139630 [TBL] [Abstract][Full Text] [Related]
8. Proteus mirabilis fimbriae: construction of an isogenic pmfA mutant and analysis of virulence in a CBA mouse model of ascending urinary tract infection. Massad G; Lockatell CV; Johnson DE; Mobley HL Infect Immun; 1994 Feb; 62(2):536-42. PubMed ID: 7905463 [TBL] [Abstract][Full Text] [Related]
10. Involvement of polyphosphate kinase in virulence and stress tolerance of uropathogenic Proteus mirabilis. Peng L; Jiang Q; Pan JY; Deng C; Yu JY; Wu XM; Huang SH; Deng XY Med Microbiol Immunol; 2016 Apr; 205(2):97-109. PubMed ID: 26233310 [TBL] [Abstract][Full Text] [Related]
11. New aspects of the role of MR/P fimbriae in Proteus mirabilis urinary tract infection. Zunino P; Geymonat L; Allen AG; Preston A; Sosa V; Maskell DJ FEMS Immunol Med Microbiol; 2001 Aug; 31(2):113-20. PubMed ID: 11549418 [TBL] [Abstract][Full Text] [Related]
12. Construction of an MR/P fimbrial mutant of Proteus mirabilis: role in virulence in a mouse model of ascending urinary tract infection. Bahrani FK; Massad G; Lockatell CV; Johnson DE; Russell RG; Warren JW; Mobley HL Infect Immun; 1994 Aug; 62(8):3363-71. PubMed ID: 7913698 [TBL] [Abstract][Full Text] [Related]
13. Proteus mirabilis uroepithelial cell adhesin (UCA) fimbria plays a role in the colonization of the urinary tract. Pellegrino R; Scavone P; Umpiérrez A; Maskell DJ; Zunino P Pathog Dis; 2013 Mar; 67(2):104-7. PubMed ID: 23620155 [TBL] [Abstract][Full Text] [Related]
14. Biofilm Formation and Immunomodulatory Activity of Proteus mirabilis Clinically Isolated Strains. Fusco A; Coretti L; Savio V; Buommino E; Lembo F; Donnarumma G Int J Mol Sci; 2017 Feb; 18(2):. PubMed ID: 28212280 [TBL] [Abstract][Full Text] [Related]
15. Proteus mirabilis flagella and MR/P fimbriae: isolation, purification, N-terminal analysis, and serum antibody response following experimental urinary tract infection. Bahrani FK; Johnson DE; Robbins D; Mobley HL Infect Immun; 1991 Oct; 59(10):3574-80. PubMed ID: 1680106 [TBL] [Abstract][Full Text] [Related]